πŸ‡ΊπŸ‡Έ FDA
Patent

US 8664183

SPANX-B polypeptides and their use

granted A61KA61K2039/53A61K40/11

Quick answer

US patent 8664183 (SPANX-B polypeptides and their use) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Mar 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/53, A61K40/11, A61K40/4267, A61K45/06